Literature DB >> 31796882

Systematic reviews and randomised controlled trials on open angle glaucoma.

Richard Wormald1,2, Gianni Virgili3, Augusto Azuara-Blanco4.   

Abstract

Evidence for the effectiveness of interventions to prevent the progression of optic nerve damage in open angle glaucoma has evolved over the last 25 years. We describe that evolution through the systematic reviews on various aspects of the topic and how those reviews have highlighted the need for new trials. Though we can be confident that lowering pressure does indeed reduce the risk of progression, we still lack good evidence on the comparative effectiveness of different treatments not so much on lowering pressure but on preventing progression of the disease. This is true for different medicines, types of laser and especially for different surgical interventions. As always there is a need for more research, but this needs to be focussed on key uncertainties using core outcome sets which avoid research waste. Ultimately, our guidelines can be based on sound and comprehensive evidence of effectiveness.

Entities:  

Mesh:

Year:  2019        PMID: 31796882      PMCID: PMC7002425          DOI: 10.1038/s41433-019-0687-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  6 in total

1.  Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes.

Authors:  Liang Li; Fang Fang; Xue Feng; Pei Zhuang; Haoliang Huang; Pingting Liu; Liang Liu; Adam Z Xu; Lei S Qi; Le Cong; Yang Hu
Journal:  Neuron       Date:  2022-08-10       Impact factor: 18.688

2.  Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2.

Authors:  Breedge Callaghan; Karen Lester; Brian Lane; Xiaochen Fan; Katarzyna Goljanek-Whysall; David A Simpson; Carl Sheridan; Colin E Willoughby
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Authors:  Fang Fang; Pei Zhuang; Xue Feng; Pingting Liu; Dong Liu; Haoliang Huang; Liang Li; Wei Chen; Liang Liu; Yang Sun; Haowen Jiang; Jiangbin Ye; Yang Hu
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

4.  MiR-18a-5p Targets Connective Tissue Growth Factor Expression and Inhibits Transforming Growth Factor β2-Induced Trabecular Meshwork Cell Contractility.

Authors:  John Knox; George Bou-Gharios; Kevin J Hamill; Colin E Willoughby
Journal:  Genes (Basel)       Date:  2022-08-22       Impact factor: 4.141

Review 5.  The Role of miR-29 Family in TGF-β Driven Fibrosis in Glaucomatous Optic Neuropathy.

Authors:  Aoife Smyth; Breedge Callaghan; Colin E Willoughby; Colm O'Brien
Journal:  Int J Mol Sci       Date:  2022-09-06       Impact factor: 6.208

6.  Comparing silicone oil-induced ocular hypertension with other inducible glaucoma models in mice.

Authors:  Jie Zhang; Yang Hu
Journal:  Neural Regen Res       Date:  2020-09       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.